105499-32-9 Usage
Uses
Used in Pharmaceutical Synthesis:
(S)-Tetrahydro-2H-pyran-2-carboxylic acid is used as a building block for the synthesis of various pharmaceuticals and natural products. Its unique structure allows it to be a key component in the development of new drugs, contributing to the advancement of medicinal chemistry.
Used in Antifungal and Antibacterial Applications:
(S)-Tetrahydro-2H-pyran-2-carboxylic acid is used as an active ingredient in the development of novel drugs for the treatment of infectious diseases. Its potential antifungal and antibacterial properties make it a promising candidate for combating resistant strains of pathogens.
Used in Organic Synthesis:
In the field of organic synthesis, (S)-Tetrahydro-2H-pyran-2-carboxylic acid is used as a versatile intermediate for the preparation of complex organic molecules. Its reactivity and compatibility with various synthetic routes make it a valuable compound for researchers in organic chemistry.
Used in Medicinal Chemistry Research and Development:
(S)-Tetrahydro-2H-pyran-2-carboxylic acid is utilized in the research and development of new therapeutic agents. Its potential applications in medicinal chemistry have led to further exploration of its properties and mechanisms of action, with the aim of discovering innovative treatments for various diseases and conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 105499-32-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,5,4,9 and 9 respectively; the second part has 2 digits, 3 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 105499-32:
(8*1)+(7*0)+(6*5)+(5*4)+(4*9)+(3*9)+(2*3)+(1*2)=129
129 % 10 = 9
So 105499-32-9 is a valid CAS Registry Number.
105499-32-9Relevant articles and documents
Substituted Pyrrolidines and Methods of Use
-
Paragraph 1518, (2018/04/20)
The invention discloses compounds of Formula (I) wherein R1, R2, R2A, R3, R3A, R4, and R5 are as defined herein. The present invention relates to compounds and their use in the treatment of cystic fibrosis, methods for their production, pharmaceutical compositions comprising the same, and methods of treating cystic fibrosis by administering a compound of the invention.
Iridium-catalyzed enantioselective hydrogenation of unsaturated heterocyclic acids
Song, Song,Zhu, Shou-Fei,Pu, Liu-Yang,Zhou, Qi-Lin
supporting information, p. 6072 - 6075 (2013/07/05)
Spiral binding: A highly enantioselective hydrogenation of unsaturated heterocyclic acids has been developed by using chiral iridium/spirophosphino oxazoline catalysts (see scheme; BArF-=tetrakis[3,5- bis(trifluoromethyl)phenyl]borate, Boc=tert-butoxycarbonyl). This reaction provided an efficient method for the preparation of optically active heterocyclic acids with excellent enantioselectivities. Copyright